S Burghaus1, T Fehm2, P A Fasching3, S Blum1, S K Renner1, F Baier1, T Brodkorb1, C Fahlbusch1, S Findeklee1, L Häberle4, K Heusinger1, T Hildebrandt1, J Lermann1, O Strahl1, G Tchartchian5, B Bojahr5, A Porn2, M Fleisch6, S Reicke7, T Füger7, C-P Hartung8, J Hackl1, M W Beckmann1, S P Renner1. 1. Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. 2. Department of Obstetrics and Gynecology, University of Duesseldorf, Duesseldorf, Germany. 3. Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany; Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA. 4. Biostatistics Unit, Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. 5. Certified Centre for Endometriosis at the MIC Klinik, Berlin, Germany. 6. HELIOS University Hospital Wuppertal, Wuppertal, Germany. 7. MIC Centre, Women Health Clinic Dr. Geisenhofer, Munich, Germany. 8. Rems-Murr-Klinik, Schorndorf, Germany.
Abstract
INTRODUCTION: Endometriosis is a heterogeneous disease characterized by a range of different presentations. It is usually diagnosed when patients present with pain and/or infertility, but it has also been diagnosed in asymptomatic patients. Because of the different diagnostic approaches and diverse therapies, time to diagnosis can vary considerably and the definitive diagnosis may be delayed, with some cases not being diagnosed for several years. Endometriosis patients have many unmet needs. A systematic registration and follow-up of endometriosis patients could be useful to obtain an insight into the course of the disease. The validation of biomarkers could contribute to the development of diagnostic and predictive tests which could help select patients for surgical assessment earlier and offer better predictions about patients who might benefit from medical, surgical or other interventions. The aim is also to obtain a better understanding of the etiology, pathogenesis and progression of the disease. MATERIAL AND METHODS: To do this, an online multicenter documentation system was introduced to facilitate the establishment of a prospective multicenter case-control study, the IEEP (International Endometriosis Evaluation Program) study. We report here on the first 696 patients with endometriosis included in the program between June 2013 and June 2015. RESULTS: A documentation system was created, and the structure and course of the study were mapped out with regard to data collection and the collection of biomaterials. CONCLUSION: The documentation system permits the history and clinical data of patients with endometriosis to be recorded. The IEEP combines this information with biomaterials and uses it for scientific studies. The recorded data can also be used to evaluate clinical quality control measures such as the certification parameters used by the EEL (European Endometriosis League) to assess certified endometriosis centers.
INTRODUCTION:Endometriosis is a heterogeneous disease characterized by a range of different presentations. It is usually diagnosed when patients present with pain and/or infertility, but it has also been diagnosed in asymptomatic patients. Because of the different diagnostic approaches and diverse therapies, time to diagnosis can vary considerably and the definitive diagnosis may be delayed, with some cases not being diagnosed for several years. Endometriosispatients have many unmet needs. A systematic registration and follow-up of endometriosispatients could be useful to obtain an insight into the course of the disease. The validation of biomarkers could contribute to the development of diagnostic and predictive tests which could help select patients for surgical assessment earlier and offer better predictions about patients who might benefit from medical, surgical or other interventions. The aim is also to obtain a better understanding of the etiology, pathogenesis and progression of the disease. MATERIAL AND METHODS: To do this, an online multicenter documentation system was introduced to facilitate the establishment of a prospective multicenter case-control study, the IEEP (International Endometriosis Evaluation Program) study. We report here on the first 696 patients with endometriosis included in the program between June 2013 and June 2015. RESULTS: A documentation system was created, and the structure and course of the study were mapped out with regard to data collection and the collection of biomaterials. CONCLUSION: The documentation system permits the history and clinical data of patients with endometriosis to be recorded. The IEEP combines this information with biomaterials and uses it for scientific studies. The recorded data can also be used to evaluate clinical quality control measures such as the certification parameters used by the EEL (European Endometriosis League) to assess certified endometriosis centers.
Entities:
Keywords:
biomarker; case control study; diagnostics; endometriosis; epidemiology
Authors: S Kissler; N Hamscho; S Zangos; I Wiegratz; S Schlichter; C Menzel; N Doebert; F Gruenwald; T J Vogl; R Gaetje; A Rody; E Siebzehnruebl; G Kunz; G Leyendecker; M Kaufmann Journal: BJOG Date: 2006-06-02 Impact factor: 6.531
Authors: A D Ebert; U Ulrich; J Keckstein; M Müller; A E Schindler; M Sillem; H-R Tinneberg; R L De Wilde; K-W Schweppe Journal: Gynecol Obstet Invest Date: 2013-02-07 Impact factor: 2.031
Authors: James M N Duffy; Kirana Arambage; Frederico J S Correa; David Olive; Cindy Farquhar; Ray Garry; David H Barlow; Tal Z Jacobson Journal: Cochrane Database Syst Rev Date: 2014-04-03
Authors: Stefanie Burghaus; Sebastian D Schäfer; Matthias W Beckmann; Iris Brandes; Christian Brünahl; Radek Chvatal; Jan Drahoňovský; Wojciech Dudek; Andreas D Ebert; Christine Fahlbusch; Tanja Fehm; Peter Martin Fehr; Carolin C Hack; Winfried Häuser; Katharina Hancke; Volker Heinecke; Lars-Christian Horn; Christian Houbois; Christine Klapp; Heike Kramer; Harald Krentel; Jan Langrehr; Heike Matuschewski; Ines Mayer; Sylvia Mechsner; Andreas Müller; Armelle Müller; Michael Müller; Peter Oppelt; Thomas Papathemelis; Stefan P Renner; Dietmar Schmidt; Andreas Schüring; Karl-Werner Schweppe; Beata Seeber; Friederike Siedentopf; Horia Sirbu; Daniela Soeffge; Kerstin Weidner; Isabella Zraik; Uwe Andreas Ulrich Journal: Geburtshilfe Frauenheilkd Date: 2021-04-14 Impact factor: 2.915
Authors: Felix Zeppernick; Magdalena Zeppernick; Elisabeth Janschek; Monika Wölfler; Sebastian Bornemann; Laura Holtmann; Frank Oehmke; Iris Brandes; Chi Mi Scheible; Darius Salehin; Sigrid Vingerhagen Pethick; Alexander Stephan Boosz; Bernhard Krämer; Martin Sillem; Klaus Bühler; Jörg Keckstein; Karl Werner Schweppe; Ivo Meinhold-Heerlein Journal: Geburtshilfe Frauenheilkd Date: 2020-02-21 Impact factor: 2.915
Authors: Simon Blum; Peter A Fasching; Thomas Hildebrandt; Johannes Lermann; Felix Heindl; Tilman Born; Hannah Lubrich; Sophia Antoniadis; Karina Becker; Christine Fahlbusch; Katharina Heusinger; Stefanie Burghaus; Matthias W Beckmann; Alexander Hein Journal: Arch Gynecol Obstet Date: 2021-08-26 Impact factor: 2.344